Clinical Trials Logo

Clinical Trial Summary

This is a performance study to test the sensitivity and specificity of the BioFire FilmArray Lower Respiratory Tract Infection (LRTI) Panel. The purpose of this study is to prospectively collect and test residual Bronchoalveolar lavage (BAL) and sputum specimens and generate performance data to support regulatory classification of the FilmArray LRTI as an in vitro diagnostic (IVD) in the US, European Union (EU), Canada, and other regions.


Clinical Trial Description

BioFire Diagnostics, LLC (BioFire; a bioMerieux company), has developed a polymerase chain reaction (PCR), high-resolution melting analysis instrument called the FilmArray. The FilmArray Lower Respiratory Tract Infection (LRTI) Panel is a test designed for use with the FilmArray that identifies common bacterial, viral, and fungal microorganisms as well as antimicrobial resistance gene targets associated with lower respiratory tract infections. The FilmArray LRTI Panel also provides quantitation for some bacterial analytes.

Clinical performance evaluations will be initiated at a minimum of three sites to determine the clinical performance of the FilmArray LRTI Panel for each of the analytes on the panel when testing bronchoalveolar lavage (BAL, including mini-BAL) and sputum (including endotracheal aspirates) specimens from subjects with suspected lower respiratory tract (LRT) infections. The intention is for these performance data to support regulatory classifications of the FilmArray LRTI Panel as an in vitro diagnostic device in the US, European Union (EU), Canada, and other regions. The study sites selected will have expertise in the diagnosis of LRTIs, and will be able to conduct the evaluation in accordance with this protocol and Good Clinical Practices (GCP). Prior to performing the prospective clinical evaluation, each participating site will have the necessary Institutional Review Board (IRB) or Ethics Committee (EC) reviews.

Specimens for inclusion in this study will be residual, de-identified BAL or sputum specimens leftover from clinician-ordered lower respiratory pathogen testing.

Comparator testing will be performed using de-identified specimen aliquots at a central reference laboratory and at BioFire.

This study is funded by BioFire Diagnostics, LLC. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03361670
Study type Observational
Source BioFire Diagnostics, LLC
Contact
Status Completed
Phase N/A
Start date October 2016
Completion date July 2017

See also
  Status Clinical Trial Phase
Completed NCT03191071 - An Algorithm to Decide on Antibiotic Prescription in Lower Respiratory Tract Infection in Primary Care N/A
Not yet recruiting NCT05534555 - Point of Care Testing Using FebriDx in Primary Care: a Mixed Methods Feasibility Study N/A
Recruiting NCT05423847 - Triage UltraSound in Tb Endemic Regions
Completed NCT04239521 - The Epidemiology, Management, and the Associated Burden of Related Conditions in Alopecia Areata
Terminated NCT04225897 - A Study to Learn About the Effects of Sisunatovir in Infants With Respiratory Syncytial Virus Lower Respiratory Tract Infection. Phase 2
Recruiting NCT04829188 - Comparative Effectiveness of Readmission Reduction Interventions for Individuals With Sepsis or Pneumonia N/A
Active, not recruiting NCT03460171 - Clinical Features, Outcome and Prognosis of Human Metapneumovirus (hMPV) Lower Respiratory Tract Infections in Adult Inpatients
Withdrawn NCT04267822 - Study of RV521 in the Treatment of Adult Subjects Who Have Undergone HCT With an URTI With RSV Phase 2
Completed NCT02979626 - Evaluation of Moderate to Severe Influenza Outcomes in Children
Completed NCT04602234 - Diagnostic of Lower Respiratory Tract Infection by Lung Ultrasonography in General Practice N/A
Completed NCT03379779 - Evaluation the Association of Microbiome Between Respiratory Tract Samples and Stool Samples in Pneumonic Patients Accompanied by Respiratory Failure
Not yet recruiting NCT06331364 - TREATment of Lower Respiratory Tract Infection in Sri Lanka (TREAT-SL) N/A
Completed NCT04320862 - COVID-19 Pandemic Response Network